Table 3.

Surgical details

Variables	Total (n = 203)	Fused BAV (n = 165)	2-sinus BAV (n = 38)	p
Median age at surgery	62 [54.0, 68.4]	62.4 [54.9, 68.4]	56.9 [49.3, 68.9]	0.2
Type of procedure				0.2
Bioprosthetic valve	77 (37.9)	65 (39.4)	12 (31.6)
Bioprosthetic valve and aortic graft	22 (10.8)	17 (10.3)	5 (13.2)
Mechanical valve	47 (23.2)	38 (23.0)	9 (23.7)
Mechanical valve and aortic graft	20 (9.9)	15 (9.1)	5 (13.2)
TAVI	18 (8.9)	14 (8.5)	4 (10.5)
Composite graft	14 (6.9)	13 (7.9)	1 (2.6)
Other	2 (1.0)	2 (1.2)	0 (0.0)
Aortic graft only	2 (1.0)	0 (0.0)	2 (5.3)
Primary indication for surgery				0.4
Aortic stenosis w/or w/o aortic dilatation	116 (75.9)	122 (73.9)	32 (84.2)	0.2
Aortic regurgitation w/or w/o aortic dilatation	29 (14.3)	27 (16.4)	2 (5.3)	0.1
Aortic dilatation	7 (3.4)	5 (3.0)	2 (5.3)	0.6
Mixed aortic stenosis and regurgitation	6 (3.0)	4 (2.4)	2 (5.3)
Endocarditis	3 (1.5)	3 (1.8)	0 (0.0)
Aortic dissection	2 (1.0)	2 (1.2)	0 (0.0)

Procedural details of 203 patients receiving endovascular or surgical intervention of the aortic valve or proximal aorta during the follow-up period. Indication and procedure type as stated in the procedural report in the electronic health journal. Numbers are count (percentage) or median [IQR]

TAVI transcatheter aortic valve implantation